Strategic JV Synergy Leverage the Teva Takeda joint venture structure to cross-sell generics and authorized generics across both Teva and Takeda channels, combining Teva’s market access with Takeda’s strong distribution in Japan to accelerate funnel growth.

Portfolio Growth Target expansion opportunities across the portfolio of generic molecules, authorized generics, LLPs, and specialty assets to address unmet patient needs and diversify revenue streams in steady or growing markets.

Regional Strength Capitalize on Takeda’s established distribution presence in Japan and Teva’s marketing excellence to pursue both domestic and cross-border sales in Asia, leveraging existing relationships and regulatory familiarity.

Tech Enablement Utilize the current tech stack (DocuSign, PHP, Apache) to streamline contract workflows, automate approvals, and accelerate deal cycles with healthcare providers, distributors, and partners.

Financial Upsell Position opportunities around revenue growth levers given the company’s mid-market revenue range; pursue volume-based agreements, risk-sharing pricing, and value-based supply arrangements with customers seeking cost-effective generics.